Go to the list of all blogs
Abhoy Sarkar's Avatar
published in Blogs
Apr 27, 2023

Novartis AG (NVS, $100.59) was a top gainer this month, soaring +20.34%

Novartis AG (NVS, $100.59) has emerged as one of the top gainers in the pharmaceutical industry this month, with an impressive 20.34% increase in its share price. This remarkable growth is a result of several factors, including a generally positive trend in the industry and strong earning results. In this article, we will delve deeper into these contributing factors and discuss the implications of NVS's RSI indicator in the overbought zone.

An analysis of the pharmaceutical industry reveals a generally positive trend, with 88.24% of the 57 major pharmaceutical stocks experiencing an uptrend for the month ending April 24, 2023. This strong performance has undoubtedly had a positive impact on NVS's share price, as the company benefits from the overall bullish sentiment in the sector.

Novartis AG's impressive share price increase can also be attributed to its strong earning results. The company has recently reported positive developments in its drug pipeline, leading to increased investor confidence and a subsequent boost in its stock price. These promising developments, coupled with the company's solid financial performance, have likely played a significant role in the stock's rapid appreciation this month.

The Relative Strength Index (RSI) is a widely-used technical analysis tool that measures the velocity and magnitude of price changes to determine whether a security is overbought or oversold. An RSI value above 70 indicates that a security is overbought, while a value below 30 indicates that it is oversold.

NVS's RSI indicator has been sitting in the overbought zone for 21 days, which could suggest that a price pull-back is imminent. This is because the longer a stock remains in the overbought zone, the more likely it is that investors will start selling to lock in profits, leading to a decrease in demand and a subsequent decline in the stock price.

Novartis AG's remarkable 20.34% increase in share price this month can be attributed to the positive trends in the pharmaceutical industry and the company's strong earning results. However, with its RSI indicator remaining in the overbought zone for an extended period, investors should be cautious and monitor the stock closely for any signs of a potential price pull-back.

Related Ticker: NVS

NVS's RSI Indicator recovers from oversold territory

The RSI Indicator for NVS moved out of oversold territory on June 02, 2023. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In of the 22 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 55 cases where NVS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

NVS moved above its 50-day moving average on June 02, 2023 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVS advanced for three days, in of 343 cases, the price rose further within the following month. The odds of a continued upward trend are .

NVS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 16, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on NVS as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NVS turned negative on May 04, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NVS entered a downward trend on May 31, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.984) is normal, around the industry mean (6.298). P/E Ratio (30.303) is within average values for comparable stocks, (31.116). Projected Growth (PEG Ratio) (4.060) is also within normal values, averaging (3.496). Dividend Yield (0.035) settles around the average of (0.027) among similar stocks. P/S Ratio (4.105) is also within normal values, averaging (4.102).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 81.1B. The market cap for tickers in the group ranges from 72.83K to 419.89B. LLY holds the highest valuation in this group at 419.89B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was 1%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 1%. DCHPF experienced the highest price growth at 52%, while CHJTF experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was 3%. For the same stocks of the Industry, the average monthly volume growth was -22% and the average quarterly volume growth was 9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 28
P/E Growth Rating: 57
Price Growth Rating: 54
SMR Rating: 52
Profit Risk Rating: 59
Seasonality Score: 13 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of health care and nutritional products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Lichtstrasse 35
Phone
+41 613241111
Employees
101703
Web
https://www.novartis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FARM1.860.04
+2.20%
Farmer Brothers Company
CARM6.500.12
+1.88%
Carisma Therapeutics
MPLN1.660.01
+0.61%
MultiPlan Corp
SQSP29.72-0.25
-0.83%
Squarespace
PSX96.02-1.01
-1.04%
Phillips 66

NVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVS has been loosely correlated with AZN. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if NVS jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
+0.47%
AZN - NVS
60%
Loosely correlated
+0.84%
MRK - NVS
54%
Loosely correlated
+0.52%
SNY - NVS
51%
Loosely correlated
-0.35%
JNJ - NVS
46%
Loosely correlated
+0.86%
GILD - NVS
44%
Loosely correlated
-0.22%
More
Sergey Savastiouk's Avatar
published in Blogs
Mar 14, 2023
How to Start Trading Penny Stocks

How to Start Trading Penny Stocks

Penny stocks have long been marginalized within the professional investment community, oftentimes being painted with a broad brush of simply being “too risky.” Leonardo DiCaprio’s depiction of the penny stock peddling conman, Jordan Belfort, in the Wolf of Wall Street certainly didn’t help.Here are four reasons to start trading them now. Reason #1: Let’s State the Obvious -- Penny Stocks are Cheap A single share of Apple Inc. costs over $350.
Dmitry Perepelkin's Avatar
published in Blogs
Mar 14, 2023
5 Habits that Lead to Successful Investing

5 Habits that Lead to Successful Investing

To consistently make money in this industry, you need emotional fortitude, an analytical mind, and a willingness to self-reflect. Despite trading and investing being two different activities, these principles can be applied to both.Conversely, investors with good habits often become great traders.  Rather than full sentences for titles, we’ve labeled each of our top-five investing habits using a single word principle.
Allana's Avatar
published in Blogs
Mar 23, 2023
What’s the Difference Between Data Analytics and Machine Learning?

What’s the Difference Between Data Analytics and Machine Learning?

Artificial intelligence (AI) technology is developing rapidly.Data mining can deliver raw numbers, but it does not necessarily provide actionable insights. Structure is necessary to taking abstract information and extracting commonalities, like averages, ratios, and percentages.
Sergey Savastiouk's Avatar
published in Blogs
Mar 13, 2023
4 Tips for Fast, Effective Stock Analysis

4 Tips for Fast, Effective Stock Analysis

With just a few clicks, an investor can search for individual stocks, categories of stocks, sectors, or investment themes, and then he or she can conduct a full range of technical and fundamental analysis within seconds.All powered by Artificial Intelligence.  Below, we give you 5 tips for fast, effective stock analysis using Tickeron’s Screener.
Sergey Savastiouk's Avatar
published in Blogs
Mar 20, 2023
5 Golden Principles in Investing

5 Golden Principles in Investing

You have enough faith in that stock, based on research, that the return will equal or exceed the investment.  Do unto others.The principles outlined here will ensure that happens.  Principle #1: Diversification Investors can’t be one-dimensional when constructing a portfolio.
John Jacques's Avatar
published in Blogs
Mar 24, 2023
If Hedge Funds are Using AI to Invest, Why Shouldn’t You?

If Hedge Funds are Using AI to Invest, Why Shouldn’t You?

Some of the world’s biggest financial institutions have devoted multi-million dollar budgets to developing algorithms that can find patterns in the market, identify trends, and perform automated trading designed to take advantage of even the smallest price movements. The AI revolution is so big that as it stands today, the world’s five biggest hedge funds all use systems-based approaches to trade financial markets.Indeed, quantitative trading hedge funds now manage $918 billion (according to HFR), which amounts to 30% of the $3 trillion hedge fund industry – a percentage continues to grow with each year that passes.
Sergey Savastiouk's Avatar
published in Blogs
Mar 15, 2023
The five most important Lessons Learned After 10,000 hours of Trading

The five most important Lessons Learned After 10,000 hours of Trading

Ten thousand hours of active trading, broken down into forty-hour weeks, amounts to almost five years. Having surpassed that milestone myself, I now understand why it's significant for any trader's journey. The early years taught me valuable lessons that have shaped my approach to trading. It's a misconception that great traders are born with innate talent. The truth is that it takes years of...
Edward Flores's Avatar
published in Blogs
Mar 12, 2023
What's the Difference Between Tokens and Altcoins?

What's the Difference Between Tokens and Altcoins?

Between their inherently technical nature, multiple varieties and sub-varieties, and endless terminology, cryptocurrency (defined here as digital or virtual currencies that are encrypted using cryptography, powered by the immutable digital ledger known as the blockchain) represents a whole, complex world.All altcoins possess their own blockchain, independent from their source code, that records all transactions of their native coins. Many altcoins are variants, or forks, of Bitcoin that leverage that cryptocurrency’s open-source protocol as the basis.
Edward Flores's Avatar
published in Blogs
Mar 26, 2023
Why it Pays to Invest in Dividend Stocks Over the Long Term

Why it Pays to Invest in Dividend Stocks Over the Long Term

Where smaller, more volatile companies can placate shareholders with higher returns, larger companies often use dividend payouts to entice new investors and hold their existing ones. These low-risk options may not work for every investment approach, but dividend-producing stocks can offer great benefits under the right circumstances – especially for portfolios built for the long-term.Beyond the ability to rely on these semi-regular payouts as an income stream – a strategy favored by retirees – dividends are an excellent vehicle for compounding earnings through reinvestment.
Edward Flores's Avatar
published in Blogs
Apr 02, 2023
How Artificial Intelligence Can Improve Fintech

How Artificial Intelligence Can Improve Fintech

Artificial intelligence (AI) and fintech have an inherent compatibility that has become clearer as each sector has matured, with recent growth and successes on their own accord bringing new ideas about how they can work together.AI can analyze information at far greater quantities (and far more quickly) than any human, making it a natural fit to help fintech firms streamline and automate processes that benefit customers and businesses alike. Fintech has brought a revolution of convenience to the finance world.